Skip to content

Drug interactions

Bosentan + Efavirenz

Severity: Moderate

Bosentan and Efavirenz: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz is a CYP3A4 inducer and bosentan is metabolised by CYP3A4 and CYP2C9, so bosentan exposure is more likely to fall than rise. Altered bosentan levels could change efficacy or hepatotoxicity risk.

What this interaction means in plain words

Bosentan and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Efavirenz belongs to Anti Virals.

Evidence level: Low

Why it happens

Efavirenz modulates CYP3A4 and CYP2C9, altering bosentan metabolism, with induction likely predominating.

What to do

Monitor clinical response in pulmonary hypertension and liver function tests regularly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Efavirenz?

MediHelp rates the interaction as moderate. Bosentan and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz is a CYP3A4 inducer and bosentan is metabolised by CYP3A4 and CYP2C9, so bosentan exposure is more likely to fall than rise. Altered bosentan levels could change efficacy or hepatotoxicity risk.

How serious is the interaction between Bosentan and Efavirenz?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response in pulmonary hypertension and liver function tests regularly.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in